Filters:
802 Projects | 553 Researchers | $379,618,805 Invested
2025
University of Illinois at Chicago
Steven Ackerman, PhD
Development of novel CCR3 chemokine receptor peptide and small molecule functionally selective biased antagonists to treat neuroinflammation in Alzheimer’s disease.
2025
Monash University
Joanne Ryan, PhD
Leveraging a large scale randomized clinical trial to determine whether statins can prevent Alzheimer’s Disease neuropathology and dementia
2025
Emory University
Thomas Kukar, PhD
Development of a granulin biologic to treat progranulin deficient FTD.
2025
Stanford University
Giuseppe Barisano, MD, PhD
Assessing the diagnostic and prognostic value of perivascular spaces imaging in cognitive impairment and dementia through a novel fully-automated robust algorithm
2025
Foundation for the National Institutes of Health, Inc.
Tatiana Lagos , MBA
Alzheimer’s Disease Blood-Based Biosignature for Predicting Clinical Progression
2025
Circular Genomics Inc
Nikolaos Mellios, MD, PhD
Alzheimer’s disease specificity and sensitivity analyses of circRNA blood biomarkers
2025
University of Gothenburg
Henrik Zetterberg, MD, PhD
Quality control (QC) program for CSF and plasma biomarkers for Alzheimer’s disease
2025
Sunbird Bio
Vijay Parthasarathy
Proof-of-Principal clinical study for blood based extracellular vesicle bound biomarker signatures quantifying brain alpha synuclein aggregation state
2025
Banner Health
Nicholas Ashton, PhD
Determining %p-tau217 and MTBR-243 by immunoassay
2024
MoCA Cognition
Ziad Nasreddine
Scientific validation of a digital MoCA for use in the general practice